Mental Health

AMC Health Achieves HITRUST Certification Demonstrating the Highest Level of Information Protection Assurance

HITRUST Certification furthers AMC Health's commitment to deliver rapid transformation to the healthcare industry while maintaining data security and equity.NEW…

2 years ago

BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

BURLINGTON, Mass. and JERUSALEM, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

2 years ago

Second-time Awardees CyncHealth, PointClickCare, Innsena Granted $80,000 Racial Equity in Postpartum Care Federal Funding

Department of Health and Human Services recognizes innovative program with proven outcomes for improving postpartum care for at-risk mothers in…

2 years ago

Mental Health Technologies (MHT) Patents SmarTest(TM) Technology

Automate Behavioral Health and Substance Use Screening Through MHT's SmarTest™ Platform.AURORA, IL / ACCESSWIRE / February 20, 2024 / Mental…

2 years ago

Wellin5 and Kintsugi Health Announce Innovative Partnership to Transform Mental Health Care

CARLSBAD, Calif.--(BUSINESS WIRE)--Wellin5, the premier provider of online counseling, proudly announces a new partnership with Kintsugi, an AI mental health…

2 years ago

PharmAla Data to be Published in ACS Chemical Neuroscience

Scientific Journal Article follows notable IP updates, including publication of key PCT Patent Application, presentation at International Society for Research…

2 years ago

Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,…

2 years ago

60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris

Candida auris (C. auris) is a dangerous drug-resistant fungal pathogen emerging in U.S. hospitalsTafenoquine’s presumed mode of action against C.…

2 years ago

VitalHub UK Expands Healthtech Portfolio into Middle East through a Partnership with ADHDS

TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF) and its subsidiary, VitalHub UK…

2 years ago

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds

TEL AVIV, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical…

2 years ago